CoChat

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l-Dopa1

BOYD, A. E., LEBOVITZ, HAROLD E., FELDMAN, JEROME M. · 1971 · The Journal of Clinical Endocrinology & Metabolism
Cited by 84

The DOI matches its Crossref record.

Abstract

The present study was designed to determine if l-dopa alters endocrine function in humans. Patients with Parkinson's disease underwent control studies that included determination of basal 24 hr urinary 17-hydroxy and keto steroids and their response to metyrapone, urinary gonadotropins, serum thyroxine, 24 hr 131I uptake by thyroid gland and the plasma glucose, insulin and growth hormone responses to oral glucose, iv glucose, iv tolbutamide and iv insulin. During the third week of l-dopa therapy (6.0 g/day) the studies were repeated. l-dopa had no effect on thyroid or adrenal function. Metyrapone response and urinary excretion of gonadotropins were unaltered. Glucose decay constants and insulin secretion following the iv glucose and tolbutamide were not changed. The oral glucose tolerance was modified in that early insulin secretion (0 to 120 min) was significantly inhibited (60.6% of control study) and late plasma glucose (3 to 5 hr) was elevated. Plasma growth hormone was elevated following l-dopa and was not suppressed by either oral or iv glucose. The studies indicate that l-dopa causes an alteration in the response to oral glucose, and a stimulation of growth hormone secretion. The control studies in the Parkinsonian patients indicated that impaired growth hormone release from insulin-induced hypoglycemia (44% of patients) and abnormal iv glucose tolerance (50% of patients) may be associated with the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-33-5-829

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 84

Metadata

Authors
BOYD, A. E., LEBOVITZ, H. E., & FELDMAN, J. M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1971-11
Volume
33
Issue
5
Pages
829-837
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2020104218
Cited by
84
References
0
FWCI
5.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l-Dopa1. https://app.cochat.ai/papers/10.1210/jcem-33-5-829
The paper
BOYD, A. E., LEBOVITZ, H. E., & FELDMAN, J. M. (1971). Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l-Dopa1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-33-5-829

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.